DOI: https://dx.doi.org/10.18203/2320-1770.ijrcog20222813
Published: 2022-10-28

A clinical audit of Pap smear test for screening of premalignant and malignant cervical lesions

Tanya Kumar, Ankit Aneja, Satwant Kaur, Sandhya P. Gulia

Abstract


Background: Cervical cancer, the second most common type of cancer in females, can be easily screened and prevented by Papanicolaou smear test which is a very simple, effective and inexpensive testing modality. The clinical audit aimed to estimate the rate of routine testing as well as the prevalence of various findings of Pap smear tests done at a tertiary level hospital.

Methods: It was an analytical cross-sectional study that utilised results of 100 pap smear tests chosen against a set of exclusion and inclusion criteria out of the total 719 pap smears done at Adesh Medical College and Hospital between the duration of 1 January 2022 to 31 May 2022.

Results: Only 4.29% of total patients that attended gynaecology OPD got a Pap smear done. A mere 22% patients of those under study came for routine testing. 93% of these 100 patients were negative for intraepithelial lesions, of which 42% were normal, 35% showed non-neoplastic changes and infection was seen in 16% of patients. 7% showed epithelial cell abnormality and 0% had malignant changes.

Conclusions: The acceptance of Pap smear for routine screening continues to be low in the Indian setting. There is a massive need to spread awareness among the general public about the importance of Pap smear Test.


Keywords


Pap smear, Cervical cancer, Cancer screening, Clinical audit

Full Text:

PDF

References


WHO-cervical cancer key facts. Available at: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer. Accessed on 12 September 2022

Maheshwari A, Kumar N, Mahantshetty U. Gynecological cancers: A summary of published Indian data. South Asian J Cancer. 2016;5(3):112-20.

Cervical Cancer India’s Country profile. Available at: https://www.who.int/publications/m/item/cervical-cancer-ind-country-profile-2021. Accessed on 12 September 2022.

Ghim SJ, Basu PS, Jenson A. Cervical cancer: etiology, pathogenesis, treatment, and future vaccines. Asian Pac J Cancer Prev. 2002;3(3):207-14.

Nicolae-Tiberiu P, Ioana P. HPV Infections and its role in carcinogenesis. Int J Med Dentist. 2019;23(1):12-6.

Carter JR, Ding Z, Rose BR. HPV infection and cervical disease: a review. Aust N Z J Obstet Gynaecol. 2011;51(2):103-8.

Shield PW, Daunter B, Wright RG. The Pap smear revisited. Aust N Z J Obstet Gynaecol. 1987;27(4):269-83.

Milojevic J, Krsic V, Pivac B. Negative predictive value of PAP smear in patients with leukoplakia patterns on colposcopy, Int J Gynecolog Cancer. 2021;31(3).

Cabrera S. Pap-smears allow the identification of protein biomarkers to diagnose endometrial cancer. Int J Gynecol Cancer. 2021;31(3).

Ashtarian H PhD, Mirzabeigi E Bs, Mahmoodi E Bs, Khezeli M. Knowledge about cervical cancer and pap smear and the factors influencing the pap test screening among women. Int J Community Based Nurs Midwifery. 2017;5(2):188-95.

Sachan PL, Singh M, Patel ML, Sachan R. A study on cervical cancer screening using Pap smear test and clinical correlation. Asia Pac J Oncol Nurs. 2018;5(3):337-41.

Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 202(12):1789-99.

HPV information centre. Fact sheet: ICO information centre on HPV and cancer human papillomavirus and related diseases reports. Available at: http://www.hpvcentre.net/statistics/reports/XWX.pdf. Accessed on 12 September 2022.

Wright TC. Cervical cancer screening in the 21st century: is it time to retire the PAP smear? Clin Obstet Gynecol. 2007;50(2):313-23.

Bal MS, Goyal R, Suri AK, Mohi MK. Detection of abnormal cervical cytology in papanicolaou smears. J Cytol. 2012;29:45-7.

Bhutia K, Puri M, Gami N, Aggarwal K, Trivedi SS. Persistent inflammation on pap smear: Does it warrant evaluation? Indian J Cancer. 2011;48:220-2.

Barouti E, Farzaneh F, Sene A. The pathogenic microorganism in papanicolaou vaginal smears and correlation with inflammation. J Family Reproduct Health. 2013;7:23-7.

Narasimha A, Vasavi B, Kumar H, Sapna M. An audit of Pap smear cytology. J South Asian Federat Obstetr Gynaecol. 2011;3(3):121-4.

Shanmugham D, Vijay A, Rangaswamy T. Colposcopic evaluation of patient with persistant inflammatory papsmear. Sch J Appl Med Sci. 2014;2:1010-3.

Maleki A, Ahmadnia E, Avazeh A, Mazloomzadeh S, Molaei B, Jalilvand A, et al. Prevalence of abnormal papanicolaou test results and related factors among women living in Zanjan, Iran. Asian Pac J Cancer Prev. 2015;16:6935-9.